181 related articles for article (PubMed ID: 10499596)
1. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
Chen X; Bonnefoi H; Diebold-Berger S; Lyautey J; Lederrey C; Faltin-Traub E; Stroun M; Anker P
Clin Cancer Res; 1999 Sep; 5(9):2297-303. PubMed ID: 10499596
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite alterations plasma DNA of primary breast cancer patients.
Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC
Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742
[TBL] [Abstract][Full Text] [Related]
3. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancer.
Wang Q; Larson PS; Schlechter BL; Zahid N; Finnemore E; de las Morenas A; Blanchard RA; Rosenberg CL
Int J Cancer; 2003 Oct; 106(6):923-9. PubMed ID: 12918071
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite alterations in serum DNA of patients with colorectal cancer.
Kölble K; Ullrich OM; Pidde H; Barthel B; Diermann J; Rudolph B; Dietel M; Schlag PM; Scherneck S
Lab Invest; 1999 Sep; 79(9):1145-50. PubMed ID: 10496533
[TBL] [Abstract][Full Text] [Related]
6. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
[TBL] [Abstract][Full Text] [Related]
7. Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.
Silva JM; Silva J; Sanchez A; Garcia JM; Dominguez G; Provencio M; Sanfrutos L; Jareño E; Colas A; España P; Bonilla F
Clin Cancer Res; 2002 Dec; 8(12):3761-6. PubMed ID: 12473587
[TBL] [Abstract][Full Text] [Related]
8. The detection of oesophageal adenocarcinoma by serum microsatellite analysis.
Eisenberger CF; Stoecklein NH; Jazra S; Hosch SB; Peiper M; Scheunemann P; Am Esch JS; Knoefel WT
Eur J Surg Oncol; 2006 Nov; 32(9):954-60. PubMed ID: 16584865
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability and loss of heterozygosity in breast cancer.
Yee CJ; Roodi N; Verrier CS; Parl FF
Cancer Res; 1994 Apr; 54(7):1641-4. PubMed ID: 8137273
[TBL] [Abstract][Full Text] [Related]
10. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.
Silva JM; Dominguez G; Garcia JM; Gonzalez R; Villanueva MJ; Navarro F; Provencio M; San Martin S; España P; Bonilla F
Cancer Res; 1999 Jul; 59(13):3251-6. PubMed ID: 10397273
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma.
Goessl C; Heicappell R; Münker R; Anker P; Stroun M; Krause H; Müller M; Miller K
Cancer Res; 1998 Oct; 58(20):4728-32. PubMed ID: 9788629
[TBL] [Abstract][Full Text] [Related]
12. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
Sozzi G; Musso K; Ratcliffe C; Goldstraw P; Pierotti MA; Pastorino U
Clin Cancer Res; 1999 Oct; 5(10):2689-92. PubMed ID: 10537330
[TBL] [Abstract][Full Text] [Related]
13. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients].
Zhang H; Li Z; Chen M; Zhang G; Xu K
Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):298-300. PubMed ID: 12133406
[TBL] [Abstract][Full Text] [Related]
14. RER and LOH association with sporadic colorectal cancer in Taiwanese patients.
Tsai MH; Yang YC; Chen KH; Jiang JK; Chou SJ; Chiang TC; Jan HS; Lou MA
Hepatogastroenterology; 2002; 49(45):672-7. PubMed ID: 12063967
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite analysis of serum DNA in patients with oral squamous cell carcinoma.
Kakimoto Y; Yamamoto N; Shibahara T
Oncol Rep; 2008 Nov; 20(5):1195-200. PubMed ID: 18949421
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.
Smeds J; Wärnberg F; Norberg T; Nordgren H; Holmberg L; Bergh J
Acta Oncol; 2005; 44(1):41-9. PubMed ID: 15848905
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
[TBL] [Abstract][Full Text] [Related]
18. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
19. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
